These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 20945488)
1. Evaluation of cell disruption effects on primary recovery of antibody fragments using microscale bioprocessing techniques. Rayat AC; Micheletti M; Lye GJ Biotechnol Prog; 2010; 26(5):1312-21. PubMed ID: 20945488 [TBL] [Abstract][Full Text] [Related]
2. Use of focused acoustics for cell disruption to provide ultra scale-down insights of microbial homogenization and its bioprocess impact--recovery of antibody fragments from rec E. coli. Li Q; Aucamp JP; Tang A; Chatel A; Hoare M Biotechnol Bioeng; 2012 Aug; 109(8):2059-69. PubMed ID: 22383367 [TBL] [Abstract][Full Text] [Related]
3. Growth and productivity impacts of periplasmic nuclease expression in an Escherichia coli Fab' fragment production strain. Nesbeth DN; Perez-Pardo MA; Ali S; Ward J; Keshavarz-Moore E Biotechnol Bioeng; 2012 Feb; 109(2):517-27. PubMed ID: 21898368 [TBL] [Abstract][Full Text] [Related]
4. Capture of human Fab fragments by expanded bed adsorption with a mixed mode adsorbent. Hansen MB; Lihme A; Spitali M; King D Bioseparation; 1999; 8(1-5):189-93. PubMed ID: 10734570 [TBL] [Abstract][Full Text] [Related]
5. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm. Venturi M; Seifert C; Hunte C J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962 [TBL] [Abstract][Full Text] [Related]
6. [One amino acid mutation in an anti-CD20 antibody fragment that affects the yield bacterial secretion and the affinity]. Liu YX; Xiong DS; Fan DM; Shao XF; Xu YF; Zhu ZP; Yang CZ Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):272-6. PubMed ID: 15969005 [TBL] [Abstract][Full Text] [Related]
7. Mimic of a large-scale diafiltration process by using ultra scale-down rotating disc filter. Ma G; Aucamp J; Gerontas S; Eardley-Patel R; Craig A; Hoare M; Zhou Y Biotechnol Prog; 2010; 26(2):466-76. PubMed ID: 19938066 [TBL] [Abstract][Full Text] [Related]
8. The simplex algorithm for the rapid identification of operating conditions during early bioprocess development: case studies in FAb' precipitation and multimodal chromatography. Chhatre S; Konstantinidis S; Ji Y; Edwards-Parton S; Zhou Y; Titchener-Hooker NJ Biotechnol Bioeng; 2011 Sep; 108(9):2162-70. PubMed ID: 21455935 [TBL] [Abstract][Full Text] [Related]
9. A microscale yeast cell disruption technique for integrated process development strategies. Wenger MD; DePhillips P; Bracewell DG Biotechnol Prog; 2008; 24(3):606-14. PubMed ID: 18410155 [TBL] [Abstract][Full Text] [Related]
10. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli]. Xiong DS; Zheng MJ; Liu YX; Xu YF; Wang JH; Yang CZ Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):673-8. PubMed ID: 15973988 [TBL] [Abstract][Full Text] [Related]
11. An ultra scale-down approach to study the interaction of fermentation, homogenization, and centrifugation for antibody fragment recovery from rec E. coli. Li Q; Mannall GJ; Ali S; Hoare M Biotechnol Bioeng; 2013 Aug; 110(8):2150-60. PubMed ID: 23475508 [TBL] [Abstract][Full Text] [Related]
12. Dual salt precipitation for the recovery of a recombinant protein from Escherichia coli. Balasundaram B; Sachdeva S; Bracewell DG Biotechnol Prog; 2011; 27(5):1306-14. PubMed ID: 21626723 [TBL] [Abstract][Full Text] [Related]
13. Engineering of Escherichia coli to improve the purification of periplasmic Fab' fragments: changing the pI of the chromosomally encoded PhoS/PstS protein. Humphreys DP; Heywood SP; King LM; Bowering LC; Turner JP; Lane SE Protein Expr Purif; 2004 Sep; 37(1):109-18. PubMed ID: 15294288 [TBL] [Abstract][Full Text] [Related]
15. [Three-step purification of preparative-scale antiCD20 (Fab')2]. Wang JH; Yang M; Fan DM; Xu YS; Xiong DS; Yang CZ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):622-5. PubMed ID: 19024400 [TBL] [Abstract][Full Text] [Related]
16. Ultra scale-down approach for the prediction of full-scale recovery of ovine polycolonal immunoglobulins used in the manufacture of snake venom-specific Fab fragment. Neal G; Christie J; Keshavarz-Moore E; Shamlou PA Biotechnol Bioeng; 2003 Jan; 81(2):149-57. PubMed ID: 12451551 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments. Thillaivinayagalingam P; O'Donovan K; Newcombe AR; Keshavarz-Moore E J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):88-96. PubMed ID: 16720112 [TBL] [Abstract][Full Text] [Related]
18. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability. Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice. Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251 [TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunoassay: conjugation of the Fab' fragment of rabbit IgG with beta-D-galactosidase from E. coli and its use for immunoassay. Kato K; Fukui H; Hamaguchi Y; Ishikawa E J Immunol; 1976 Jun; 116(6):1554-60. PubMed ID: 774986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]